Cherubism Gene Sh3bp2 is Important for Optimal Bone Formation, Osteoblast Differentiation, and Function

Overview

Journal Am J Orthod Dentofacial Orthop

Publisher Elsevier

Specialty Dentistry

Date 2010 Aug 10

PMID 20691350

Citations 7

Authors

Padma M Mukherjee

Chiachien J Wang

I-Ping Chen

Toghrul Jafarov

Bjorn R Olsen

Yasuyoshi Ueki

Ernst J Reichenberger

Affiliations

Soon will be listed here.

Abstract

Introduction: Cherubism is a human genetic disorder that causes bilateral symmetrical enlargement of the maxilla and the mandible in children. It is caused by mutations in SH3BP2. The exact pathogenesis of the disorder is an area of active research. Sh3bp2 knock-in mice were developed by introducing a Pro416Arg mutation (Pro418Arg in humans) in the mouse genome. The osteoclast phenotype of this mouse model was recently described.

Methods: We examined the bone phenotype of the cherubism mouse model, the role of Sh3bp2 during bone formation, osteoblast differentiation, and osteoblast function.

Results: We observed delays in early postnatal development of homozygous Sh3bp2(KI/KI) mice, which exhibited increased growth plate thickness and significantly decreased trabecular bone thickness and bone mineral density. Histomorphometric and microcomputed tomography analyses showed bone loss in the cranial and appendicular skeletons. Sh3bp2(KI/KI) mice also exhibited a significant decrease in osteoid formation that indicated a defect in osteoblast function. Calvarial osteoblast cell cultures had decreased alkaline phosphatase expression and mineralization, suggesting reduced differentiation potential. Gene expression of osteoblast differentiation markers such as collagen type I, alkaline phosphatase, and osteocalcin were decreased in osteoblast cultures from Sh3bp2(KI/KI) mice.

Conclusions: These data suggest that Sh3bp2 regulates bone homeostasis through not only osteoclast-specific effects, but also through effects on osteoblast differentiation and function.

Citing Articles

Regulation of differentiation and generation of osteoclasts in rheumatoid arthritis.

Niu Q, Gao J, Wang L, Liu J, Zhang L Front Immunol. 2022; 13:1034050.

PMID: 36466887 PMC: 9716075. DOI: 10.3389/fimmu.2022.1034050.

RANKL-independent osteoclastogenesis in the SH3BP2 cherubism mice.

Kittaka M, Yoshimoto T, Hoffman H, Levitan M, Ueki Y Bone Rep. 2020; 12:100258.

PMID: 32258251 PMC: 7118294. DOI: 10.1016/j.bonr.2020.100258.

Molecular and cellular characterizations of human cherubism: disease aggressiveness depends on osteoclast differentiation.

Kadlub N, Sessiecq Q, Mandavit M, Coulomb lHermine A, Badoual C, Galmiche L Orphanet J Rare Dis. 2018; 13(1):166.

PMID: 30236129 PMC: 6148781. DOI: 10.1186/s13023-018-0907-2.

Cherubism misdiagnosed as giant cell tumor: a case report and review of literature.

Jiao Y, Zhou M, Yang Y, Zhou J, Duan X Int J Clin Exp Med. 2015; 8(3):4656-63.

PMID: 26064398 PMC: 4443232.

A c.1244G>A (p.Arg415Gln) mutation in SH3BP2 gene causes cherubism in a Turkish family: report of a family with review of the literature.

Sekerci A, Balta B, Dundar M, Hu Y, Reichenberger E, Etoz O Med Oral Patol Oral Cir Bucal. 2014; 19(4):e340-4.

PMID: 24608212 PMC: 4119308. DOI: 10.4317/medoral.19496.

References

Ueki Y, Lin C, Senoo M, Ebihara T, Agata N, Onji M . Increased myeloid cell responses to M-CSF and RANKL cause bone loss and inflammation in SH3BP2 "cherubism" mice. Cell. 2007; 128(1):71-83. DOI: 10.1016/j.cell.2006.10.047. View

Deckert M, Tartare-Deckert S, Hernandez J, Rottapel R, Altman A . Adaptor function for the Syk kinases-interacting protein 3BP2 in IL-2 gene activation. Immunity. 1998; 9(5):595-605. DOI: 10.1016/s1074-7613(00)80657-3. View

Yao Z, Li P, Zhang Q, Schwarz E, Keng P, Arbini A . Tumor necrosis factor-alpha increases circulating osteoclast precursor numbers by promoting their proliferation and differentiation in the bone marrow through up-regulation of c-Fms expression. J Biol Chem. 2006; 281(17):11846-55. DOI: 10.1074/jbc.M512624200. View

Jones W, GERRIE J, Pritchard J . Cherubism--familial fibrous dysplasia of the jaws. J Bone Joint Surg Br. 1950; 32-B(3):334-47. DOI: 10.1302/0301-620X.32B3.334. View

Kitaura H, Zhou P, Kim H, Novack D, Ross F, Teitelbaum S . M-CSF mediates TNF-induced inflammatory osteolysis. J Clin Invest. 2005; 115(12):3418-27. PMC: 1283943. DOI: 10.1172/JCI26132. View

Chen G, Dimitriou I, La Rose J, Ilangumaran S, Yeh W, Doody G . The 3BP2 adapter protein is required for optimal B-cell activation and thymus-independent type 2 humoral response. Mol Cell Biol. 2007; 27(8):3109-22. PMC: 1899947. DOI: 10.1128/MCB.01014-06. View

Jain V, Gamanagatti S, Gadodia A, Kataria P, Bhatti S . Non-familial cherubism. Singapore Med J. 2007; 48(9):e253-7. View

Winslow M, Pan M, Starbuck M, Gallo E, Deng L, Karsenty G . Calcineurin/NFAT signaling in osteoblasts regulates bone mass. Dev Cell. 2006; 10(6):771-82. DOI: 10.1016/j.devcel.2006.04.006. View

Richtsmeier J, Baxter L, Reeves R . Parallels of craniofacial maldevelopment in Down syndrome and Ts65Dn mice. Dev Dyn. 2000; 217(2):137-45. DOI: 10.1002/(SICI)1097-0177(200002)217:2<137::AID-DVDY1>3.0.CO;2-N. View

10.

Jones W, GERRIE J, Pritchard J . Cherubism--a familial fibrous dysplasia of the jaws. Oral Surg Oral Med Oral Pathol. 1952; 5(3):292-305. DOI: 10.1016/0030-4220(52)90129-1. View

11.

Ueki Y, Tiziani V, SantAnna C, Fukai N, Maulik C, Garfinkle J . Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism. Nat Genet. 2001; 28(2):125-6. DOI: 10.1038/88832. View

12.

Parfitt A, Drezner M, Glorieux F, Kanis J, MALLUCHE H, Meunier P . Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 1987; 2(6):595-610. DOI: 10.1002/jbmr.5650020617. View

13.

Southgate J, Sarma U, Townend J, Barron J, Flanagan A . Study of the cell biology and biochemistry of cherubism. J Clin Pathol. 1999; 51(11):831-7. PMC: 500977. DOI: 10.1136/jcp.51.11.831. View

14.

Franzoso G, Carlson L, Xing L, Poljak L, Shores E, Brown K . Requirement for NF-kappaB in osteoclast and B-cell development. Genes Dev. 1998; 11(24):3482-96. PMC: 316809. DOI: 10.1101/gad.11.24.3482. View

15.

Deckert M, Rottapel R . The adapter 3BP2: how it plugs into leukocyte signaling. Adv Exp Med Biol. 2006; 584:107-14. DOI: 10.1007/0-387-34132-3_8. View

16.

Liao B, Zhang J . Null mutations in human and mouse orthologs frequently result in different phenotypes. Proc Natl Acad Sci U S A. 2008; 105(19):6987-92. PMC: 2383943. DOI: 10.1073/pnas.0800387105. View

17.

Miah S, Hatani T, Qu X, Yamamura H, Sada K . Point mutations of 3BP2 identified in human-inherited disease cherubism result in the loss of function. Genes Cells. 2004; 9(11):993-1004. DOI: 10.1111/j.1365-2443.2004.00784.x. View

18.

Jones W . Cherubism. A thumbnail sketch of its diagnosis and a conservative method of treatment. Oral Surg Oral Med Oral Pathol. 1965; 20(5):648-53. DOI: 10.1016/0030-4220(65)90111-8. View

19.

Foucault I, Liu Y, Bernard A, Deckert M . The chaperone protein 14-3-3 interacts with 3BP2/SH3BP2 and regulates its adapter function. J Biol Chem. 2002; 278(9):7146-53. DOI: 10.1074/jbc.M209509200. View